CytoDyn Inc. Quarterly Amortization of Intangible Assets in USD from Q4 2018 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
CytoDyn Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from Q4 2018 to Q2 2022.
  • CytoDyn Inc. Amortization of Intangible Assets for the quarter ending May 31, 2022 was $100K, a 66.7% decline year-over-year.
  • CytoDyn Inc. Amortization of Intangible Assets for the twelve months ending May 31, 2022 was $700K, a 61.1% decline year-over-year.
  • CytoDyn Inc. annual Amortization of Intangible Assets for 2022 was $100K, a 85.7% decline from 2021.
  • CytoDyn Inc. annual Amortization of Intangible Assets for 2021 was $700K, a 61.1% decline from 2020.
  • CytoDyn Inc. annual Amortization of Intangible Assets for 2020 was $1.8M, a 10% decline from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $700K $100K -$200K -66.7% Mar 1, 2022 May 31, 2022 10-K 2023-09-14
Q1 2022 $900K $100K -$400K -80% Dec 1, 2021 Feb 28, 2022 10-Q 2022-04-11
Q4 2021 $1.3M $200K -$300K -60% Sep 1, 2021 Nov 30, 2021 10-Q 2022-01-10
Q3 2021 $1.6M $300K -$200K -40% Jun 1, 2021 Aug 31, 2021 10-Q 2021-10-12
Q2 2021 $1.8M $300K Mar 1, 2021 May 31, 2021 10-K 2022-08-15
Q1 2021 $500K $0 0% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-11
Q4 2020 $500K Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-10
Q3 2020 $500K +$2.9K +0.58% Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-12
Q1 2020 $500K Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q3 2019 $497K Jun 1, 2019 Aug 31, 2019 10-Q 2020-01-09
Q4 2018 $153K Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.